Issue link: https://www.e-digitaleditions.com/i/1515319
20 February 2024 Inhalation Dry powder and soft mist inhalers e devices we make are based on widely accepted designs. We make dry powder inhalers (DPI) and soft mist inhalers (SMI). Our capsule DPI MRX003 is on the market; our SMI MRX004 is a preferred option for both biologics and ultra-low carbon foot- print. e FDA agrees that our MRX006 is a 505j substitutable match for vilanterol/umeclidinium/ fluticasone multidose DPI; MRX002 is a see through cannister for HFA/HFO pMDI formulations. We Will Launch You. Merxin, Ltd. UK: +44 1553 403070 info@merxin.com www.merxin.com Plasma process for treating MDI canisters H&T Presspart offers a unique plasma process—man- ufactured under license from Portal Medical Ltd—for treating the internal surfaces of metered dose inhaler (MDI) canisters, which can help ensure the active drug content does not stick to the canister wall. is fluorocarbon polymerization (FCP) plasma treatment process can improve the surface energy performance of an MDI canister, which can enhance drug stability in formulations where interactions with the alumin- ium substrate can lead to product degradation and reduced shelf life. H&T Presspart UK: +44 1254 582233 blackburn@presspart.com www.presspart.com Calibration and mensuration MSP, a Division of TSI, recognizes the need for using trustworthy and consistent inhalation test systems for drug development and QC. Without proper cleaning, calibration and mensuration, it cannot be assumed that your equipment is in compliance. MSP offers a variety of service options within USP <1058> guidelines to ensure your analytical instruments per- form within given specifications—avoiding bridging studies and saving you time and money. Keep your test equipment in compliance with regular service. MSP, a Division of TSI US: +1 651 287-8100 mspsales@tsi.com www.mspcorp.com Respiratory drug product development software Fusion Process Development (FPD) is the perfect companion module to Fusion Inhaler Testing (FIT) for respiratory drug product R&D. FPD has auto- mated Design of Experiments (DoE) and data mod- eling for formulation and process R&D. FPD enables you to create companion testing designs for your formulation and device design studies with full bi- directional Chromatography Data Software (CDS) testing automation. Automated CDS testing and data retrieval includes handling of complex data from cas- cade impaction testing and dissolution testing. And FPD operates under full regulatory compliance to maintain data integrity. S-Matrix ® US: +1 707 441-0406 sales@smatrix.com www.smatrix.com